CuraGen, Miami Institute for Human Genomics, BioServe, SeraCare Life Sciences, US House of Representatives, Agencourt, Affymetrix, Nugen, National Genome Research Network, Illumina | GenomeWeb
$50M-$55M Revenues ‘Achievable Target’ for 454 This Year, CuraGen Says
CuraGen last week said it continues to expect its 454 Life Sciences subsidiary to generate between $50 million and $55 million in revenue this year.
The company originally made its projection in January. Last week, during the company’s first-quarter conference call, CEO Frank Armstrong said: “From our view of the first quarter, this continues to be an achievable target.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.